Simplex Trading
BCRX icon

Simplex Trading’s BioCryst Pharmaceuticals BCRX Stock Holding History

Simplex Trading’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29M Buy
+240,900
New +$1.87M ﹤0.01% 1712
2025
Q4 		– Sell
-69,400
Closed -$526K – 8554
2025
Q3 		$526K Sell
69,400
-66,800
-49% -$556K ﹤0.01% 3752
2025
Q2 		$1.22M Buy
136,200
+75,900
+126% +$707K ﹤0.01% 2576
2025
Q1 		$452K Sell
60,300
-28,900
-32% -$233K ﹤0.01% 3494
2024
Q4 		$670K Sell
89,200
-51,600
-37% -$392K ﹤0.01% 3248
2024
Q3 		$1.07M Sell
140,800
-8,900
-6% -$67.7K ﹤0.01% 2865
2024
Q2 		$925K Sell
149,700
-78,200
-34% -$432K ﹤0.01% 2995
2024
Q1 		$1.16M Buy
227,900
+131,200
+136% +$738K ﹤0.01% 2963
2023
Q4 		$579K Sell
96,700
-21,300
-18% -$123K ﹤0.01% 3534
2023
Q3 		$835K Sell
118,000
-97,400
-45% -$700K ﹤0.01% 2860
2023
Q2 		$1.52M Buy
215,400
+64,200
+42% +$515K ﹤0.01% 2206
2023
Q1 		$1.26M Sell
151,200
-83,800
-36% -$807K ﹤0.01% 2369
2022
Q4 		$2.7M Sell
235,000
-153,700
-40% -$1.92M ﹤0.01% 1642
2022
Q3 		$4.9M Buy
388,700
+155,300
+67% +$2M 0.01% 1221
2022
Q2 		$2.47M Sell
233,400
-65,300
-22% -$674K ﹤0.01% 1668
2022
Q1 		$4.86M Buy
298,700
+115,300
+63% +$1.85M ﹤0.01% 1268
2021
Q4 		$2.54M Sell
183,400
-70,200
-28% -$929K ﹤0.01% 1784
2021
Q3 		$4.13M Buy
253,600
+11,800
+5% +$186K ﹤0.01% 1373
2021
Q2 		$3.82M Buy
+241,800
New +$3.29M ﹤0.01% 1432
2021
Q1 		– Sell
-553
Closed -$411K – 8803
2020
Q4 		$411K Buy
553
+493
+822% +$2.54K ﹤0.01% 3682
2020
Q3 		$20K Sell
60
-213
-78% -$913 ﹤0.01% 6356
2020
Q2 		$130K Buy
273
+210
+333% +$839 ﹤0.01% 4507
2020
Q1 		$12K Buy
63
+53
+530% +$146 ﹤0.01% 6334
2019
Q4 		$3K Sell
10
-74
-88% -$186 ﹤0.01% 6859
2019
Q3 		$24K Sell
84
-32
-28% -$100 ﹤0.01% 5664
2019
Q2 		$43K Buy
116
+44
+61% +$265 ﹤0.01% 4990
2019
Q1 		$58K Buy
72
+52
+260% +$445 ﹤0.01% 4881
2018
Q4 		$16K Sell
20
-3
-13% -$23 ﹤0.01% 5498
2018
Q3 		$17K Buy
23
+6
+35% +$40 ﹤0.01% 6069
2018
Q2 		$9K Buy
+17
New +$94 ﹤0.01% 6385
2018
Q1 		– Sell
-221
Closed -$7K – 6124
2017
Q4 		$7K Sell
221
-378
-63% -$1.83K ﹤0.01% 4172
2017
Q3 		$22K Buy
599
+208
+53% +$1.06K ﹤0.01% 3055
2017
Q2 		$21K Sell
391
-357
-48% -$2.17K ﹤0.01% 3243
2017
Q1 		$35K Buy
748
+350
+88% +$2.44K ﹤0.01% 2683
2016
Q4 		$60K Buy
398
+279
+234% +$1.45K ﹤0.01% 1978
2016
Q3 		$4K Buy
119
+18
+18% +$72 ﹤0.01% 4413
2016
Q2 		$14K Sell
101
-16
-14% -$50 ﹤0.01% 3220
2016
Q1 		$3K Buy
117
+50
+75% +$222 ﹤0.01% 4413
2015
Q4 		$2K Sell
67
-377
-85% -$3.75K ﹤0.01% 4442
2015
Q3 		$59K Buy
444
+394
+788% +$5.26K ﹤0.01% 1844
2015
Q2 		$11K Sell
50
-86
-63% -$978 ﹤0.01% 2959
2015
Q1 		$4K Sell
136
-87
-39% -$901 ﹤0.01% 3621
2014
Q4 		$43K Buy
+223
New +$2.46K 0.01% 1472

Other funds holding BCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Simplex Trading's BCRX Position: Q1 2026 in Review

Simplex Trading opened a new position in BioCryst Pharmaceuticals (BCRX) in Q1 2026: 53,965 shares worth $514K. The stake represents ﹤0.01% of the portfolio and ranks #3224 among its holdings. This is a return to the name: Simplex Trading previously reported a position in BCRX as recently as Q3 2025.

Simplex Trading first reported a position in BCRX in Q4 2014 and has held it in 27 quarters since. The position peaked at $1.87M in Q4 2020. 301 funds tracked by Wall St. Rank hold BCRX as of Q1 2026.

  • Simplex Trading held 53,965 shares of BioCryst Pharmaceuticals worth $514K as of Q1 2026.
  • BioCryst Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3224 holding.
  • Simplex Trading first reported a position in BioCryst Pharmaceuticals in Q4 2014 and has held it in 27 quarters since.
  • Simplex Trading's BioCryst Pharmaceuticals position peaked at $1.87M in Q4 2020.
  • 301 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.